The following devices were also listed in this report: 2.0mm 22-13-5 ss cable/slv set; cat# 3704-0-510; lot# 46790102, 2.0mm 22-13-5 ss cable/slv set; cat# 3704-0-510; lot# 46790108, simplex p with tobramycin 1 pack; cat# 6197-9-001; lot# mlu112, simplex p with tobramycin 1 pack; cat# 6197-9-001; lot# mlu112.It cannot be determined which, if any of these devices may have caused or contributed to the patient's experience.An event regarding alleged infection involving a dall miles cable was reported.The event was not confirmed.Method & results: device evaluation and results: could not be performed as no items associated with the event were returned for evaluation.Medical records received and evaluation: a review of the operative reports, office notes, x-rays by the consulting clinician indicated "there is no examination of explanted components and no bacterial culture confirming an organism which may have been masked by pre-operative intravenous antibiotics.Pre operative sed rate and benign x-rays and frozen sections do not confirm sepsis.There is no documentation of recurrent drainage or "ion concentrations in the thousands" as noted in the operative report of (b)(6) 2014.Evaluation of hip pain is difficult in the multiple emergency room visits of this narcotic dependent, non-compliant patient.Based on the available medical records there is no convincing evidence in operative reports or radiology reports that there are any factors of implant design, manufacturing or materials of the revision components (the only stryker components) that were responsible for this complicated clinical picture." device history review indicated the devices accepted into final stock from the reported lot were free from discrepancies complaint history review: there has been no other event for the lot referenced and sterile lot.Conclusions: the event could not be confirmed nor the root cause determined because the devices were not returned for evaluation and insufficient medical information was provided.A review of the operative reports, office notes, x-rays by the consulting clinician indicated "there is no examination of explanted components and no bacterial culture confirming an organism which may have been masked by pre-operative intravenous antibiotics.Pre operative sed rate and benign x-rays and frozen sections do not confirm sepsis.There is no documentation of recurrent drainage or "ion concentrations in the thousands" as noted in the operative report of (b)(6) 2014.Evaluation of hip pain is difficult in the multiple emergency room visits of this narcotic dependent, non-compliant patient.Based on the available medical records there is no convincing evidence in operative reports or radiology reports that there are any factors of implant design, manufacturing or materials of the revision components (the only stryker components) that were responsible for this complicated clinical picture." a capa trend analysis was conducted for the reported failure mode and concluded infection is most likely a result from other factors not necessarily related to the device in the healthcare facility setting.If the devices and/or additional information are received, this investigation will be reopened and re-evaluated.Product surveillance will continue to monitor for trends.
|
On (b)(6) 2015 his prosthesis (competitor product) was removed and a revision of the right total hip was performed for a diagnosis of "status-post infected right hip status-post prosthesis (competitor product) placement".[.]"the report notes, "cultures negative, esr and crp normal, off antibiotics.".
|